BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3928578)

  • 1. Antistreptococcal activity of Sch 34343, a new penem antibiotic.
    Yu PK; Washington JA
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():67-71. PubMed ID: 3928578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal activity of netilmicin compared with gentamicin and streptomycin, alone and in combination with penicillin, against penicillin tolerant viridans streptococci and enterococci.
    Shanson DC; Tadayon M; Bakhtiar M
    J Antimicrob Chemother; 1986 Oct; 18(4):479-90. PubMed ID: 3095305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
    Eliopoulos GM; Reiszner E; Moellering RC
    Antimicrob Agents Chemother; 1985 Jan; 27(1):28-32. PubMed ID: 3845792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.
    Moellering RC; Wennersten C; Weinstein AJ
    Antimicrob Agents Chemother; 1973 Apr; 3(4):526-9. PubMed ID: 4208292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis.
    Dornbusch K; Henning C; Lindén E
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():109-17. PubMed ID: 2732133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity of Sch 34343 alone and in combination with gentamicin.
    Shah PM; Schneider K; Stille W
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():165-71. PubMed ID: 3897171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin tolerance among oral streptococci.
    Holbrook WP; Olafsdóttir D; Magnússon HB; Benediktsdóttir E
    J Med Microbiol; 1988 Sep; 27(1):17-22. PubMed ID: 3050106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
    Shanson DC; Tadayon M
    J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.
    Lam K; Bayer AS
    Antimicrob Agents Chemother; 1984 Aug; 26(2):260-2. PubMed ID: 6091537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial tolerance in group C and group G streptococci.
    Rolston KV; Chandrasekar PH; LeFrock JL
    J Antimicrob Chemother; 1984 Apr; 13(4):389-92. PubMed ID: 6563035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
    Elliott AM; Karam GH; Cobbs CG
    Antimicrob Agents Chemother; 1983 Dec; 24(6):847-50. PubMed ID: 6318661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
    Aubert G; Pozzetto B; Dorche G
    Pathol Biol (Paris); 1991 Dec; 39(10):1002-5. PubMed ID: 1666667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.
    Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():147-54. PubMed ID: 3897168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of combinations of penicillin or clindamycin with gentamicin or streptomycin against species of viridans streptococci.
    Duperval R; Bill NJ; Geraci JE; Washington JA
    Antimicrob Agents Chemother; 1975 Dec; 8(6):673-6. PubMed ID: 1211918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultural and electronmicroscopic studies of the effect of penicillin on tolerant oral streptococci.
    Holbrook WP; Kristinsson KG; Carley AJ; Gunnarsdóttir S
    J Med Microbiol; 1989 Dec; 30(4):267-72. PubMed ID: 2600959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis.
    Thornsberry C; Baker CN; Facklam RR
    Antimicrob Agents Chemother; 1974 Mar; 5(3):228-33. PubMed ID: 4840433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of Sch 34343, a new penem antibiotic.
    Reeves DS; Holt HA; Bywater MJ
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():57-66. PubMed ID: 3849538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci.
    Francioli P; Moreillon P; Glauser MP
    J Infect Dis; 1985 Jul; 152(1):83-9. PubMed ID: 3925031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.